Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer

Overview of attention for article published in Journal of Hematology & Oncology, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user

wikipedia: 9 Wikipedia pages

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 80 Mendeley

Summary Blogs X Wikipedia Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,051 followers.

Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive… http://t.co/Xw0Mv5as44 #breastcancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.